Aller au contenu

Clinical outcome of patients with isolated central nervous system progression on first-line pertuzumab and trastuzumab treatment for HER2-positive metastatic breast cancer in a real-life cohort.

Nom du journal : Breast Cancer

Année : 2023

Volume : 30

Page de départ : 329-341

Auteurs: Collet, L, Eberst, L, Ludovic, G, Debled, M, Hrab, L, Mouret-Reynier, MA & al,